Free Trial

InMode (INMD) Competitors

InMode logo
$14.81 +0.60 (+4.22%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$14.69 -0.12 (-0.81%)
As of 08/22/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INMD vs. NVST, LIVN, WRBY, INSP, LQDA, PRCT, LMAT, AORT, EYE, and ENOV

Should you be buying InMode stock or one of its competitors? The main competitors of InMode include Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), Artivion (AORT), National Vision (EYE), and Enovis (ENOV). These companies are all part of the "medical equipment" industry.

InMode vs. Its Competitors

Envista (NYSE:NVST) and InMode (NASDAQ:INMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

InMode has lower revenue, but higher earnings than Envista. InMode is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.55B1.41-$1.12B$0.3267.72
InMode$394.82M2.37$181.27M$2.476.00

InMode has a net margin of 44.50% compared to Envista's net margin of 2.11%. InMode's return on equity of 18.38% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.11% 4.84% 2.68%
InMode 44.50%18.38%16.35%

Envista presently has a consensus target price of $20.92, indicating a potential downside of 3.44%. InMode has a consensus target price of $18.04, indicating a potential upside of 21.82%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33
InMode
0 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.13

Envista has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, InMode has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500.

In the previous week, Envista had 3 more articles in the media than InMode. MarketBeat recorded 8 mentions for Envista and 5 mentions for InMode. InMode's average media sentiment score of 1.66 beat Envista's score of 1.32 indicating that InMode is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
7 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

68.0% of InMode shares are held by institutional investors. 0.7% of Envista shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

InMode beats Envista on 11 of the 17 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INMD vs. The Competition

MetricInModeMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$898.20M$10.77B$5.75B$9.62B
Dividend YieldN/A1.87%4.40%4.10%
P/E Ratio6.0021.2531.3026.05
Price / Sales2.3729.38432.98193.75
Price / Cash7.7924.5537.7358.48
Price / Book1.493.519.536.61
Net Income$181.27M$211.77M$3.26B$265.65M
7 Day Performance3.21%4.44%2.13%2.02%
1 Month Performance-0.80%8.85%2.80%-0.31%
1 Year Performance-8.86%-9.03%30.68%19.06%

InMode Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INMD
InMode
1.9668 of 5 stars
$14.81
+4.2%
$18.04
+21.8%
-4.4%$898.20M$394.82M6.00480Positive News
NVST
Envista
3.8405 of 5 stars
$20.75
+0.5%
$20.92
+0.9%
+20.6%$3.45B$2.51B64.8312,300
LIVN
LivaNova
1.713 of 5 stars
$53.27
-0.8%
$59.29
+11.3%
+21.4%$2.91B$1.25B-13.692,900News Coverage
Positive News
Analyst Forecast
WRBY
Warby Parker
2.2773 of 5 stars
$27.38
+0.9%
$24.06
-12.1%
+94.9%$2.88B$771.32M-391.093,780Analyst Upgrade
INSP
Inspire Medical Systems
4.9394 of 5 stars
$88.28
+0.6%
$165.62
+87.6%
-48.6%$2.61B$802.80M51.031,246News Coverage
Positive News
Short Interest ↓
LQDA
Liquidia Technologies
3.5287 of 5 stars
$27.72
+6.8%
$31.40
+13.3%
+178.7%$2.39B$14M-16.3150
PRCT
PROCEPT BioRobotics
3.5403 of 5 stars
$40.71
-2.1%
$74.88
+83.9%
-48.6%$2.27B$224.50M-26.26430News Coverage
LMAT
LeMaitre Vascular
2.1806 of 5 stars
$95.04
-0.9%
$98.00
+3.1%
+16.4%$2.15B$219.86M46.14490Positive News
AORT
Artivion
3.5596 of 5 stars
$42.81
0.0%
$39.80
-7.0%
+75.6%$2.02B$388.54M-101.921,600Analyst Forecast
Insider Trade
EYE
National Vision
2.7881 of 5 stars
$23.87
+5.0%
$24.73
+3.6%
+142.5%$1.89B$1.82B-132.6113,411Positive News
ENOV
Enovis
4.4836 of 5 stars
$29.51
-0.1%
$51.00
+72.8%
-28.7%$1.69B$2.11B-2.077,367Positive News

Related Companies and Tools


This page (NASDAQ:INMD) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners